Ray Dalio Legend Biotech Corp Transaction History
Bridgewater Associates, LP
- $20.7 Billion
- Q1 2025
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Legend Biotech Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 225,449 shares of LEGN stock, worth $7.1 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
225,449
Previous 161,723
39.4%
Holding current value
$7.1 Million
Previous $5.26 Million
45.36%
% of portfolio
0.04%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
74.4MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$218 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$212 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$188 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$180 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$118 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.27B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...